TrianglePUBLICATIONS · 36854071
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jun 10
- First author
- Flaadt T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Flaadt T
- type
- Author
- name
- Ladenstein RL
- type
- Author
- name
- Ebinger M
- type
- Author
- name
- Lode HN
- type
- Author
- name
- Arnardóttir HB
- type
- Author
- name
- Poetschger U
- type
- Author
- name
- Schwinger W
- type
- Author
- name
- Meisel R
- type
- Author
- name
- Schuster FR
- type
- Author
- name
- Döring M
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Queudeville M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Flaadt T
- type
- Author
- name
- Ladenstein RL
- type
- Author
- name
- Ebinger M
- type
- Author
- name
- Lode HN
- type
- Author
- name
- Arnardóttir HB
- type
- Author
- name
- Poetschger U
- type
- Author
- name
- Schwinger W
- type
- Author
- name
- Meisel R
- type
- Author
- name
- Schuster FR
- type
- Author
- name
- Döring M
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Queudeville M
- type
- Author
- bibliography ids
- nci-bib-1d4967229e4feee866c18f27
- book metadata
- content sha256
- 0cfce2c606dbe59d69ee79d4ba5b51392a53ea1b8513c31eedc57c07523c7eae
- document type
- citation
- dois
- 10.1200/JCO.22.01630
- electronic publication date
- display
- 2023 Feb 28
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36854071
- immutable id
- pubmed:36854071@0cfce2c606dbe59d69ee79d4ba5b51392a53ea1b8513c31eedc57c07523c7eae
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 17
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3135-3148
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36854071
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- b8e3ef358b05ec2366b1f5605c3cacb750cab2598cdeedf4d749d15c47b0405f
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Jun 10
- precision
- day
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Clinical Trial, Phase I
- Multicenter Study
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.
Preserved source evidence · Not medical advice